An RNAseq analysis of invasive breast cancer specimens from the TCGA highlighted a negative correlation between IDO1 and ESR1 gene expression, along with a significant downregulation of IDO, specifically in luminal A and B BC subtypes [71]. This evidence concerns the gene IDO1 and breast carcinoma.